Scar treatment refers to medical and surgical procedures that help improve the appearance and texture of scars. Common scar treatment options include topical creams, laser therapy, surface chemical peels, steroid injections, and silicone gel sheeting. Scars can be physically and emotionally painful, reducing an individual’s quality of life. As scarring is a natural body response to skin injuries like burns, cuts or acne, the growing instances of such skin injuries have augmented the need for effective scar treatment in China.
The Global China Scar Treatment Market Demand is estimated to be valued at US$ 19.01 Mn in 2024 and is expected to exhibit a CAGR of 1.7% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the China scar treatment are Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, and Tianjin Medical. Non-invasive procedures like laser therapy and injection therapy are gaining popularity in China due to minimal downtime and lower costs. Technological advancements are leading to development of advanced scar treatment products like laser systems, micro-needling devices and hydrogel sheets.
Market drivers
The increasing demand for minimally invasive and non-invasive aesthetic procedures in China is a major market driver. Due to growing health and appearance consciousness, Chinese consumers are opting for non-surgical scar treatments. Rising product availability through online platforms and retail stores is also fueling market growth. Growing medical tourism in China coupled with introduction of advanced scar treatment technologies will augment the market in coming years.
Current Challenges in China Scar Treatment Market
The China scar treatment market is witnessing several challenges that are restricting its growth potential. One of the key challenges is lack of awareness about the available treatment options and their efficacy among consumers. Many people are still unaware about the different scar treatment products and methods that can help in reducing the appearance and visibility of scars. This limits the demand for such products. Secondly, traditional Chinese medicines continue to dominate the healthcare landscape in China. People rely more on ancient traditional remedies rather than modern medical treatments for issues like scars. This acts as a major restraint for scar treatment products. High costs of some advanced scar reduction procedures and long duration of the full treatment process also discourages many consumers. Improving awareness, promoting traditional Chinese medicine integrated with modern scar therapies and making treatments more affordable can help overcome some of the present challenges in China.
SWOT Analysis
Strength: The China market has a very large population base which translates to a huge potential customer pool for scar treatment products and services.
Weakness: Reliance on traditional Chinese medicines limits wider acceptance of modern scar therapies. Lack of awareness about available options is also a weakness.
Opportunity: Increasing brand promotion and education campaigns can help tap into the massive untapped market potential. Integrating traditional and modern approaches presents an opportunity.
Threats: Low treatment costs and easy availability of some alternate traditional remedies act as threats. Economic slowdowns can negatively impact discretionary spends on scar treatments.
Geographical Regions
In terms of value, eastern provinces like Guangdong, Jiangsu, Zhejiang hold the major share of over 60% in the China scar treatment market currently. This is due to higher disposable incomes and increasing inclination towards advanced aesthetic treatments in these more developed regions. The secondary concentration exists in central Chinese provinces of Henan, Hubei and Hunan contributing around 15-20% market share. The northern region comprising provinces like Shandong, Hebei, Shanxi has around 10-15% scar treatment market share currently. The fastest growing region projected during the forecast period is expected to be Western China due to rising living standards and healthcare spends. Provinces like Sichuan, Chongqing, Guizhou, Yunnan are projected to experience higher than average annual growth rates in scar treatment demand.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it